FilingReader Intelligence
Otsuka Holdings boosts profits, eyes new growth in 2025
February 20, 2025 at 07:04 PM UTC•By FilingReader AI
Otsuka Holdings (TSE:4578) reported a banner year in 2024, with profits surging 176.7% to ¥347.27 billion, driven by strong pharmaceutical and nutraceutical sales. Key products like REXULTI/RXULTI and LONSURF fueled growth, prompting increased shareholder dividends and signaling confidence in the company's strategic direction. The company projects FY2025 operating profit to increase by 15.9% to ¥375 billion.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
TSE:4578•Tokyo Stock Exchange
News Alerts
Get instant email alerts when Otsuka Holdings publishes news
Free account required • Unsubscribe anytime